CORI Short Information, Corium International Inc.

Twenty Trading Day Totals
Total Shorted Volume	543,533
Total Actual Volume	12,621,055

Averages
Average Short Volume	27,177
Average Short Percentage	26.21%

Is there a CORI Short Squeeze or Breakout about to happen?

See the CORI Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2018-11-26	12.67	12.68	12.745	12.65	4,072,230	162,941	35.0473
2018-11-23	12.66	12.65	12.68	12.64	598,882	34,790	37.2588
2018-11-21	12.67	12.71	12.71	12.64	377,910	31,228	41.9263
2018-11-20	12.68	12.67	12.68	12.64	427,780	9,012	9.9391
2018-11-19	12.65	12.67	12.69	12.65	221,549	19,426	58.7865
2018-11-16	12.62	12.65	12.66	12.62	439,205	13,088	20.1190
2018-11-15	12.62	12.63	12.66	12.62	344,620	27,319	39.9956
2018-11-14	12.62	12.64	12.65	12.62	188,697	10,527	21.7878
2018-11-13	12.61	12.64	12.64	12.61	204,907	13,898	39.2787
2018-11-12	12.60	12.60	12.62	12.59	516,613	24,414	17.8940
2018-11-09	12.61	12.60	12.63	12.60	493,754	26,246	26.2534
2018-11-08	12.60	12.61	12.62	12.59	370,929	15,633	22.5891
2018-11-07	12.61	12.61	12.63	12.59	589,244	13,384	11.3421
2018-11-06	12.59	12.60	12.61	12.59	441,204	18,899	17.4546
2018-11-05	12.60	12.60	12.61	12.58	433,159	22,767	19.1475
2018-11-02	12.63	12.59	12.63	12.58	608,770	21,103	12.2594
2018-11-01	12.64	12.61	12.68	12.58	691,694	22,816	14.4137
2018-10-31	12.62	12.65	12.66	12.60	533,319	14,809	20.6311
2018-10-30	12.61	12.60	12.63	12.58	562,848	18,709	19.0787
2018-10-29	12.63	12.61	12.67	12.57	503,741	22,524	39.0872

Stock Information

Corium International Inc. Company Name:

CORI Stock Symbol:

NASDAQ Market:

Get CORI Alerts

News, Short Squeeze, Breakout and More Instantly...

CORI - Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer's Disease

MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
CORI - Corium Appoints Perry Sternberg as Chief Executive Officer

MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas ...
CORI - Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025

MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its acquisition by Gurnet Point ...